Lucky to have the super talented @A_SextonOates in the team! Congrats and well deserved!

The Clevers Lab and the Rare Cancers Genomics Team (IARC/WHO) developed the first organoid model for neuroendocrine tumors. During the development of this new model, they already discovered a potential new treatment for pulmonary NETs: hubrecht.eu/nets. Talya Dayton Nicolas Alcala

Researchers from IARC and Hubrecht Institute have created “mini-tumours” of a rare cancer that affects neuroendocrine cells. They are a powerful #tool to investigate how cancer develops in these cells, and how it may be managed in the clinic. 👉See more: iarc.who.int/news-events/re…

New Cancer Cell: Rare Cancers Genomics IARC team up with Talya Dayton EMBL Barcelona to create mini-tumors of rare @cancers. A story of #biotechnology🥼🔬 & #conservation🐨, where we monitor #tumors like endangered species and witness #evolution in action cell.com/cancer-cell/fu… 🧵

NEN in a dish: A patient-derived organoid biobank illuminates potential novel therapeutic opportunities for neuroendocrine neoplasms dlvr.it/T0BlkS

How to best finish 2023? With the talented Emilie Mathian successfully defending her PhD IARC supervised by Matthieu Foll 🦋 @matthieufoll.bsky.social @FCLynnette and Liming Chen! The next generation of researchers dedicated to NET Research Foundation is ready!

Our paper on patient-derived tumor #organoids of #neuroendocrine neoplasms was published in the Dec2023 issue of @CancerCell! The Clevers Lab Hans Clevers Rare Cancers Genomics UMC Utrecht International The Netherlands Cancer Institute Maastricht UMC+ NET Research Foundation A belated 🧵 HNY everyone! cell.com/cancer-cell/fu… /1

We’re delighted that IARC’s Dr Nicolas Alcala Nicolas Alcala is among recipients of the Neuroendocrine Tumor Research Foundation’s NET Research Foundation newest neuroendocrine tumor (NET) research grants to investigators studying the most promising approaches to understanding & treating NETs!

So grateful for the continuous support from NET Research Foundation!

Dr. Nicolas Alcala is a scientist with Indian Republican. This is his first NETRF award: "Because each NET subtype carries specific DNA alterations and seems to make the immune system react differently, we believe that the interaction between tumor DNA and immune cells (1/3)

It is still time to apply if you are looking for a postdoc on single-cell and spatial omics in cancer! rarecancersgenomics.com/vacancies/

#RareDiseaseDay At IARC, the Rare Cancers Genomics Team Rare Cancers Genomics leads projects to study rare cancers. An example is the lungNENomics project, which aims to improve diagnosis & management of lung neuroendocrine tumours. More📄iarc.who.int/news-events/ra… 📺youtube.com/watch?v=5dLOA7…

Matthieu Foll 🦋 @matthieufoll.bsky.social presenting a new tool to learn about rare cancers 🔸 “reuse” data from EPIC study 🔸data about risk, exposure and lifestyle factors available 🔸 updated survival available soon Waiting to make tool publicly available #ESMOSarcomaAndRareCancers24 ESMO - Eur. Oncology

Another rare cancer Data Note from Matthieu Foll 🦋 @matthieufoll.bsky.social and the IARC Rare Cancers Genomics initiative, this time presenting PDTO data. Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms doi.org/10.1093/gigasc…

Thank you #ENETS24 for this award! The Clevers Lab Hubrecht Institute Rare Cancers Genomics UMC Utrecht International The Netherlands Cancer Institute Maastricht UMC+ EMBL Barcelona Nicolas Alcala Matthieu Foll 🦋 @matthieufoll.bsky.social @FCLynnette @DerksJules 👀 🧵about our work x.com/TalyaDayton/st… & preview cell.com/cancer-cell/ab… by Stefanie Gerstberger, MD PhD Karuna Ganesh

Congrats to émilie Mathian, the Rare Cancers Genomics team and a stellar team of expert pathologists who teamed up to advance the diagnosis of lung #neuroendocrine #tumors with emerging markers and #deeplearning 👏 sciencedirect.com/science/articl… ESMO Open

Very happy to share our latest work on pulmonary carcinoids published in Journal of Clinical Oncology: TERT Expression and Clinical Outcome in Pulmonary Carcinoids ascopubs.org/doi/10.1200/JC… Thanks to all involved! SFB1399 Department of Translational Genomics Uniklinik Köln Charlie Rudin Natasha Rekhtman MD PhD Matthieu Foll 🦋 @matthieufoll.bsky.social Alex Di Genova

We are thrilled to welcome Yuliya Lim as a PhD student in the team, under the supervision of Nicolas Alcala, L. Fernandez-Cuesta, and Matthieu Foll 🦋 @matthieufoll.bsky.social! Yuliya recieved a competitive PhD fellowship from La Ligue contre le cancer and will work on deciphering the mysteries of cancer ecosystem complexity.